From July 1, 2022 to December 31, 2022, the company has repurchased 0 shares, representing 0% for HKD 0 million. With this, the company has completed the repurchase of 229,000 shares, representing 0.03% for HKD 0.21 million under the buyback announced on June 2, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 HKD | 0.00% | +0.84% | -12.41% |
1st Jan change | Capi. | |
---|---|---|
-12.41% | 11Cr | |
+16.31% | 4.23TCr | |
+16.32% | 2.13TCr | |
+19.33% | 1.53TCr | |
+18.71% | 1.44TCr | |
+52.78% | 1.28TCr | |
-0.05% | 678.76Cr | |
-12.24% | 658.31Cr | |
-8.87% | 572.55Cr | |
+11.64% | 550.82Cr |
- Stock Market
- Equities
- 1652 Stock
- News Fusen Pharmaceutical Company Limited
- Tranche Update on Fusen Pharmaceutical Company Limited's Equity Buyback Plan announced on June 2, 2022.